These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 38514754)
1. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma. Wang Y; Zhang Y; Li Y; Huang J Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754 [TBL] [Abstract][Full Text] [Related]
2. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Erdogan S; Houslay MD Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416 [TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 4 and its inhibitors in inflammatory diseases. Jin SL; Ding SL; Lin SC Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051 [TBL] [Abstract][Full Text] [Related]
4. PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways. Mika D; Conti M Cell Signal; 2016 Jul; 28(7):719-24. PubMed ID: 26562185 [TBL] [Abstract][Full Text] [Related]
5. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma. Sahin Y Clin Exp Med; 2023 Jul; 23(3):841-851. PubMed ID: 35810257 [TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF. Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277 [TBL] [Abstract][Full Text] [Related]
7. PDE4 subtypes in cancer. Hsien Lai S; Zervoudakis G; Chou J; Gurney ME; Quesnelle KM Oncogene; 2020 May; 39(19):3791-3802. PubMed ID: 32203163 [TBL] [Abstract][Full Text] [Related]
8. An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing. Johnson KR; Nicodemus-Johnson J; Danziger RS BMC Evol Biol; 2010 Aug; 10():247. PubMed ID: 20701803 [TBL] [Abstract][Full Text] [Related]
9. Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor. Keravis T; Monneaux F; Yougbaré I; Gazi L; Bourguignon JJ; Muller S; Lugnier C PLoS One; 2012; 7(1):e28899. PubMed ID: 22247763 [TBL] [Abstract][Full Text] [Related]
10. NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues. Yougbare I; Morin C; Senouvo FY; Sirois C; Albadine R; Lugnier C; Rousseau E Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L441-50. PubMed ID: 21784969 [TBL] [Abstract][Full Text] [Related]
11. Effect of pregnancy on PDE4 cAMP-specific phosphodiesterase messenger ribonucleic acid expression in human myometrium. Leroy MJ; Méhats C; Duc-Goiran P; Tanguy G; Robert B; Dallot E; Mignot TM; Grangé G; Ferré F Cell Signal; 1999 Jan; 11(1):31-7. PubMed ID: 10206342 [TBL] [Abstract][Full Text] [Related]
12. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells. Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479 [TBL] [Abstract][Full Text] [Related]
13. Expression of mRNA encoding cAMP-specific phosphodiesterase isoforms in rat parotid glands. Imai A; Nashida T; Shimomura H Biochem Mol Biol Int; 1996 Dec; 40(6):1175-81. PubMed ID: 8988329 [TBL] [Abstract][Full Text] [Related]
14. Regulation of 3',5'-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats. Cheng D; Ren J; Gillespie DG; Mi Z; Jackson EK Hypertension; 2010 Dec; 56(6):1096-101. PubMed ID: 20975032 [TBL] [Abstract][Full Text] [Related]
15. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue. Richter W; Jin SL; Conti M Biochem J; 2005 Jun; 388(Pt 3):803-11. PubMed ID: 15717866 [TBL] [Abstract][Full Text] [Related]
16. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma. Dong W; Du D; Huang H Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163 [TBL] [Abstract][Full Text] [Related]
17. Cyclic nucleotide phosphodiesterase isoforms in human basophils and mast cells. Eskandari N; Tashrifi F; Bastan R; Andalib A; Yousefi Z; Peachell PT Int J Immunopathol Pharmacol; 2016 Dec; 29(4):654-665. PubMed ID: 26781461 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma. Zhang X; Meng X; Wang P; Luan C; Wang H Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263 [TBL] [Abstract][Full Text] [Related]
19. The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D. Mori F; Pérez-Torres S; De Caro R; Porzionato A; Macchi V; Beleta J; Gavaldà A; Palacios JM; Mengod G J Chem Neuroanat; 2010 Sep; 40(1):36-42. PubMed ID: 20347962 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis. Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]